MX2011010191A - Peptidos c6orf167 y vacunas que continen los mismos. - Google Patents

Peptidos c6orf167 y vacunas que continen los mismos.

Info

Publication number
MX2011010191A
MX2011010191A MX2011010191A MX2011010191A MX2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A
Authority
MX
Mexico
Prior art keywords
peptides
c6orf167
methods
ctls
present
Prior art date
Application number
MX2011010191A
Other languages
English (en)
Spanish (es)
Inventor
Yusuke Nakamura
Ryuji Ohsawa
Takuya Tsunoda
Sachiko Yoshimura
Tomohisa Watanabe
Yataro Daigo
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of MX2011010191A publication Critical patent/MX2011010191A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
MX2011010191A 2009-04-01 2010-03-31 Peptidos c6orf167 y vacunas que continen los mismos. MX2011010191A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21170009P 2009-04-01 2009-04-01
PCT/JP2010/002352 WO2010113495A1 (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
MX2011010191A true MX2011010191A (es) 2011-11-29

Family

ID=42827803

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010191A MX2011010191A (es) 2009-04-01 2010-03-31 Peptidos c6orf167 y vacunas que continen los mismos.

Country Status (14)

Country Link
US (1) US20120128705A1 (https=)
EP (1) EP2414383A4 (https=)
JP (1) JP5728759B2 (https=)
KR (1) KR20120034605A (https=)
CN (2) CN102448980B (https=)
AU (1) AU2010231381A1 (https=)
BR (1) BRPI1013384A2 (https=)
CA (1) CA2757210A1 (https=)
IL (1) IL215268A0 (https=)
MX (1) MX2011010191A (https=)
RU (1) RU2011144088A (https=)
SG (2) SG2014011423A (https=)
TW (1) TW201100090A (https=)
WO (1) WO2010113495A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311985A1 (en) 2005-07-27 2011-04-20 Oncotherapy Science, Inc. Sirna for treating esophageal cancer
CN105601727B (zh) * 2010-03-11 2020-01-10 肿瘤疗法科学股份有限公司 Hjurp肽及包含它们的疫苗
WO2012023259A1 (en) * 2010-08-19 2012-02-23 Oncotherapy Science, Inc. C6orf167 as a target gene for cancer therapy and diagnosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521865A (ja) * 1997-10-24 2003-07-22 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 148個のヒト分泌タンパク質
CN1351069A (zh) * 2000-10-26 2002-05-29 上海博德基因开发有限公司 一种新的多肽——鼠的同ampa受体相互作用的蛋白grip12.54和编码这种多肽的多核苷酸
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
DE60327786D1 (de) * 2002-09-12 2009-07-09 Oncotherapy Science Inc Kdr-peptide und diese enthaltende impfstoffe
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Cxadrl1またはgcud1タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
ES2364670T3 (es) * 2005-02-25 2011-09-12 Oncotherapy Science, Inc. Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk.
EP2295570A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
EP2311985A1 (en) * 2005-07-27 2011-04-20 Oncotherapy Science, Inc. Sirna for treating esophageal cancer
WO2009151691A2 (en) * 2008-03-13 2009-12-17 Celera Corporation Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof

Also Published As

Publication number Publication date
CN104774260A (zh) 2015-07-15
US20120128705A1 (en) 2012-05-24
KR20120034605A (ko) 2012-04-12
JP5728759B2 (ja) 2015-06-03
SG174998A1 (en) 2011-11-28
CA2757210A1 (en) 2010-10-07
CN102448980B (zh) 2015-04-15
CN102448980A (zh) 2012-05-09
TW201100090A (en) 2011-01-01
RU2011144088A (ru) 2013-05-10
EP2414383A4 (en) 2013-07-31
BRPI1013384A2 (pt) 2016-03-29
JP2012522488A (ja) 2012-09-27
SG2014011423A (en) 2014-05-29
AU2010231381A1 (en) 2011-11-03
IL215268A0 (en) 2011-11-30
WO2010113495A1 (en) 2010-10-07
EP2414383A1 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
EA202091251A3 (ru) Новые способы иммунотерапии нескольких видов опухолей, в том числе рака желудочно-кишечного тракта и рака желудка
MX2010014044A (es) Peptidos de epitope cdca1 y vacunas que contienen los mismos.
MX366365B (es) Peptidos de kntc2 y vacunas que los contienen.
MX362912B (es) Péptidos ube2t y vacunas que incluyen los mismos.
MX380003B (es) Péptidos topk y vacunas que incluyen los mismos.
MX2011012013A (es) Peptidos ttk y vacunas que incluyen los mismos.
MX2011010191A (es) Peptidos c6orf167 y vacunas que continen los mismos.
EP4219525A3 (en) Foxm1-derived peptide, and vaccine including same
BR112013005448A2 (pt) peptídeos de ttll4 e vacinas contendo os mesmos.
EP4353321A3 (en) Koc1-derived peptide and vaccine including same
EP3848383A3 (en) Urlc10-derived peptide and vaccine containing same
MX2012006376A (es) Peptidos mybl2 y vacunas que los contienen.
MX2021001357A (es) Peptido derivado de cdca1 y vacuna que lo contiene.
MX2015007015A (es) Peptidos sema5b y vacunas que contienen los mismos.
MX2012011666A (es) Peptidos cluap1 y vacunas que incluyen los mismos.
BR112017002212A2 (pt) peptídeo derivado de cdca1 e vacina contendo o mesmo
TH139004A (th) TTLL4 เปปไทด์และวัคซีนที่บรรจุสิ่งเดียวกัน (TTLL4 Peptides and Vaccines containing the same)
EA202090821A1 (ru) Новый метод иммунотерапии нескольких видов опухолей, таких как рак легкого, включая нмрл
MY193910A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194241A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc

Legal Events

Date Code Title Description
FG Grant or registration